Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM02434 Fibroblast

Description:

SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
ADENOSINE DEAMINASE; ADA

Affected:

Yes

Sex:

Male

Age:

7 MO (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • Publications
  • External Links
  • Images
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
Class Disorders of Nucleotide and Nucleic Acid Metabolism
Cell Type Fibroblast
Transformant Untransformed
Race White
Family Member 1
Relation to Proband proband
Confirmation Biochemical characterization after cell line submission to CCR
Species Homo sapiens
Common Name Human
Remarks Clinically affected; physical exam at birth was normal; subject was placed in protective isolation after birth and had good weight gain and no infections during the first 6 weeks; no thymic shadow seen on chest x-ray; perianal abscesses were intermittently present between one and ten months of age; normal development; normal kidneys but possible obstruction of left ureter; T cells were 44% and 46% at 3 and 9 days of age, respectively and B cells were 43% and 19%, respectively; leukopenia; immunoglobulin levels at 20 days of age were normal; deficient RBC & fibroblast ADA activity; residual ADA activity could be detected in mononuclear-cell/platelet preparations; less than 1.5% of ADA activity was seen in amniotic fluid cells; enzyme phenotypes: G6PD=B; 6PGD=A; peptidases A, C, & D=1; & PGM 1 & 3=1; donor subject is a compound heterozygote: one allele has a T>G transversion at nucleotide 911 in exon 10 of the ADA gene [911T>G] resulting in a substitution of arginine for leucine at codon 304 [Leu304Arg (L304R)] and a second allele has a C>T transition at nucleotide 466 of the ADA gene [466C>T] resulting in a substitution of cysteine for arginine at codon 156 [Arg156Cys (R156C)]; affected sister died at 9 months of age; mother is GM02433; same donor as GM02471 lymphocyte.

Characterizations

back to top
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis
 
adenosine deaminase According to the submitter, biochemical test results for this subject showed decreased enzyme activity. EC Number: 3.5.4.4; <1.5% activity.
 
Gene ADA
Chromosomal Location 20q13.11
Allelic Variant 1 608958.0005; SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
Identified Mutation LEU304ARG; In a patient with SCID due to ADA deficiency (102700) originally reported by Hirschhorn et al. (1975), Valerio et al. (1986) identified compound heterozygosity for 2 mutations in the ADA gene: one was a T-to-G transversion in exon 10, resulting in a leu304-to-arg (L304R) substitution. Functional expression studies showed that the L304R substitution resulted in ADA enzyme inactivation.
 
Gene ADA
Chromosomal Location 20q13.11
Allelic Variant 2 608958.0018; SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
Identified Mutation ARG156CYS; In 2 patients with SCID who were unusual for reportedly responding to the limited form of enzyme therapy provided by repeated partial exchange transfusions {Polmar et al. [N Engl J Med 295: 1337 (1976); Dyminski et al. [Clin Immunol Immunopathol 14: 307 (1979)]}, Hirschhorn [Hum Mutat 1: 166 (1992)] found two new missense mutations, arg156-to-cys and ser291-to-leu (102700.0019). The first of these was found in cell line GM02471 and represented a CGC-to-TGC transition at codon 156.

Phenotypic Data

back to top
Remarks Clinically affected; physical exam at birth was normal; subject was placed in protective isolation after birth and had good weight gain and no infections during the first 6 weeks; no thymic shadow seen on chest x-ray; perianal abscesses were intermittently present between one and ten months of age; normal development; normal kidneys but possible obstruction of left ureter; T cells were 44% and 46% at 3 and 9 days of age, respectively and B cells were 43% and 19%, respectively; leukopenia; immunoglobulin levels at 20 days of age were normal; deficient RBC & fibroblast ADA activity; residual ADA activity could be detected in mononuclear-cell/platelet preparations; less than 1.5% of ADA activity was seen in amniotic fluid cells; enzyme phenotypes: G6PD=B; 6PGD=A; peptidases A, C, & D=1; & PGM 1 & 3=1; donor subject is a compound heterozygote: one allele has a T>G transversion at nucleotide 911 in exon 10 of the ADA gene [911T>G] resulting in a substitution of arginine for leucine at codon 304 [Leu304Arg (L304R)] and a second allele has a C>T transition at nucleotide 466 of the ADA gene [466C>T] resulting in a substitution of cysteine for arginine at codon 156 [Arg156Cys (R156C)]; affected sister died at 9 months of age; mother is GM02433; same donor as GM02471 lymphocyte.

Publications

back to top
Daddona PE, Frohman MA, Kelley WN, Human adenosine deaminase and its binding protein in normal and adenosine deaminase-deficient fibroblast cell strains. J Biol Chem255:5681-7 1980
PubMed ID: 7380831
 
Polmar SH, Stern RC, Schwartz AL, Wetzler EM, Chase PA, Hirschhorn R, Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med295:1337-43 1976
PubMed ID: 980079
 
Hirschhorn R, Beratis N, Rosen FS, Parkman R, Stern R, Polmar S, Adenosine-deaminase deficiency in a child diagnosed prenatally. Lancet1:73-75 1975
PubMed ID: 46025
 
Polmar SH, Wetzler EM, Stern RC, Hirschhorn R, Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency. Lancet2:743-6 1975
PubMed ID: 52774

External Links

back to top
dbSNP dbSNP ID: 19388
Gene Cards ADA
Gene Ontology GO:0004000 adenosine deaminase activity
GO:0009117 nucleotide metabolism
GO:0009168 purine ribonucleoside monophosphate biosynthesis
GO:0016787 hydrolase activity
GO:0019735 antimicrobial humoral response (sensu Vertebrata)
NCBI Gene Gene ID:100
NCBI GTR 102700 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
608958 ADENOSINE DEAMINASE; ADA
OMIM 102700 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY
608958 ADENOSINE DEAMINASE; ADA
Omim Description ADA-SCID, INCLUDED
  ADENOSINE AMINOHYDROLASESEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY,INCLUDED
  ADENOSINE DEAMINASE; ADA
  SCID DUE TO ADA DEFICIENCY, INCLUDED

Images

back to top
View pedigree 

Culture Protocols

back to top
Split Ratio 1:3
Temperature 37 C
Percent CO2 5%
Medium Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not inactivated
Substrate None specified
Subcultivation Method trypsin-EDTA
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Family
  • 219
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube